Cargando…
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial
Combined pre-and post-capillary hypertension (CpcPH) is a relatively common complication of heart failure (HF) associated with a poor prognosis. Currently, there is no specific therapy approved for this entity. Recently, treatment with beta-3 adrenergic receptor (β3AR) agonists was able to improve p...
Autores principales: | Garcia-Lunar, Ines, Blanco, Isabel, Fernández-Friera, Leticia, Prat-Gonzàlez, Susanna, Jordà, Paloma, Sánchez, Javier, Pereda, Daniel, Pujadas, Sandra, Rivas, Mercedes, Solé-Gonzalez, Eduard, Vázquez, Jorge, Blázquez, Zorba, García-Picart, Juan, Caravaca, Pedro, Escalera, Noemí, Garcia-Pavia, Pablo, Delgado, Juan, Segovia-Cubero, Javier, Fuster, Valentín, Roig, Eulalia, Barberá, Joan Albert, Ibanez, Borja, García-Álvarez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188870/ https://www.ncbi.nlm.nih.gov/pubmed/32368692 http://dx.doi.org/10.1016/j.jacbts.2020.01.009 |
Ejemplares similares
-
Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension
por: García-Álvarez, Ana, et al.
Publicado: (2016) -
Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension
por: García-Lunar, Inés, et al.
Publicado: (2020) -
Dose of furosemide before admission predicts diuretic efficiency and long‐term prognosis in acute heart failure
por: Blázquez‐Bermejo, Zorba, et al.
Publicado: (2021) -
Bone marrow activation in response to metabolic syndrome and early atherosclerosis
por: Devesa, Ana, et al.
Publicado: (2022) -
The development of chronic diuretic resistance can be predicted during a heart-failure hospitalization. Results from the REDIHF registry
por: Blázquez-Bermejo, Zorba, et al.
Publicado: (2020)